Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: The Cooper Health System
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?This trial is testing two different methods for pain relief after robotic lung surgery. One method uses a newer, long-lasting painkiller. The other method uses a combination of an older painkiller, a medication that helps with pain relief, and a medication that reduces inflammation. The goal is to determine which method provides better pain control.
Eligibility Criteria
Inclusion Criteria
undergoing robotic wedge resection or lobectomy for lung mass(es)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Bupivacaine/epinephrine + dexamethasoneExperimental Treatment1 Intervention
Group II: Liposomal bupivacaineActive Control1 Intervention
Bupivacaine is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Marcaine for:
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
🇪🇺 Approved in European Union as Marcaine for:
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
🇨🇦 Approved in Canada as Sensorcaine for:
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Cooper University HospitalCamden, NJ
Loading ...
Who Is Running the Clinical Trial?
The Cooper Health SystemLead Sponsor